A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients
Clinical trial NCT06322628 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06322628
- Sponsor
- Visirna Therapeutics HK Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-22
- Primary completion
- 2026-07-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.